09/21/2818 10:18 From: Woodson C. Merrell M Uebfax Page: 3/13 sr.LabCorp Pasecsuditimmnislo D0emna79” Patient Report Patient ID: ConcrolMJSBW0092 SPninsen ID: 257-410-2371.0 Date collected: 09!!4.2018 255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB BUN Creatinine eGFR If NonAfricn Am eGFR If Africn Am BUN/Creatinine Ratio Sodium Potassium 22 0.96 83 95 23 138 4.2 mg/dL mg/dL mL/min/1.73 mL/min/1.73 8 - 27 0.76 - 1.27 01 >59 >59 10 - 24 mMO1/L 134 - 144 01 anol/L 3.5 - 5.2 01 Sample is lipemic. This may cause spurious increases in IBM, DBili, AST, ALT, and UIBC (if ordered). Clinical correlation indicated Specimen received hemolyzed. Clinical correlation indicated. Chloride 102 mmol/L 96 Carbon Dioxide, Total 20 mmol/L 20 Calcium 9.4 mg/dL 8.6 - Protein, Total 6.7 g/dL 6.0 - Albumin ♦.3 g/dL 3.6 - Globulin, Total 2.4 g/dL 1.5 A/G Ratio 1.8 1.2 Bilirubin, Total 0.3 mg/dL 0.0 Alkaline Phosphatase 71 IU/L 39 AST (SOOT) 26 IU/L 0 - The specimen was lipemic. The lipemia was cleared by ultracentrifugation before testing. However HDL, direct LDL, cholesterol and triglyceride (if ordered) were performed prior to ultracentrifugation. ALT (SGPT) • urinalysis, Routine Urinalysis Gross Exam Specific Gravity pH Urine-Color Appearance WBC Esterase Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-Qn Nitrite, Urine Microscopic Examination Microscopic follows PE+Interp(Rfx IFE),8 37 IU/L 1.027 5.5 Yellow Clear Negative Negative Negative Negative Negative Negative 0.2 Negative if indicated. 01 106 01 29 01 10.2 01 8.5 01 4.8 01 4.5 2.2 1.2 01 117 01 40 01 0 - 44 01 01 1.005 - 1.030 01 5.0 - 7.5 01 Yellow 01 Clear 01 Negative 01 Negative/Trace 01 Negative 01 Negative 01 Negative 01 Negative 01 EU/dL 0.2 - 1.0 01 Negative 01 01 iniswect09/2011SOMET RNA/REPORT ibis&mmwincomeftplimerwicordositaf